Know All About The Recently Approved Landmark Breast Cancer Drug In UK

Know All About The Recently Approved Landmark Breast Cancer Drug In UK

Credits: Canva

Text

Updated Apr 12, 2025 | 01:00 PM IST

SummaryCapivasertib is taken as a twice-daily pill, in combination with the hormone therapy fulvestrant. The drug works by blocking an abnormal protein—a part of the cancer cell’s signaling system—that tells the cells to multiply. By disrupting this signal, capivasertib slows or halts the progression of the disease.

End of Article